Glenmark Pharmaceuticals Limited — Others, 20-06-2025: Cessation

Glenmark Pharmaceuticals has announced that Mr. Rajesh Desai will cease to be an Independent Director following the completion of his term. This change has led to the reconstitution of key board committees: Mrs. Vijayalakshmi Iyer now chairs the Audit Committee, Ms. Saira Ramasastry leads the Stakeholders Relationship Committee, and Mr. Dipankar Bhattacharjee heads the Risk Management Committee. These shifts in board composition reflect governance adjustments impacting oversight functions critical to the company’s operations and stakeholder engagement.